Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schizophrenia gene identified through screening:

This article was originally published in Clinica

Executive Summary

Scientists at Reykjavik, Iceland-based deCODE Genetics and psychiatrists from the Icelandic healthcare system have identified a gene linked to schizophrenia. The gene was detected as the result of a genome-wide screen involving 400 Icelandic schizophrenic patients and an equal number of their unaffected family members. Swiss company Roche, deCODE's main corporate partner, hopes to use the result to develop new diagnostic and therapeutic tools to combat the illness.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074978

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel